Further, when BNP (15 mg/kg/day) is intravenously injected over 8 weeks in rats with permanent coronary occlusion, BNP treatment prevents cardiac hypertrophy and EF decline and decreases plasma Ang II level and collagen content in the myocardium (He et al., 2009). Here, NPPB is linked to cardiac hypertrophy.